The Foxo Technologies Inc (NYSEAMERICAN: FOXO) stock price rallied 18.9% despite the lack of news releases from the company today. However, the lack of recent news releases indicates that today’s rally could be driven by upbeat investor sentiment towards the company.
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY.
Over 6.38 million FOXO shares had changed hands at the time of writing as investors flocked to the company to buy its shares. The last significant announcement from the company was its collaboration with DataRobot on August 17, 2023.
Top Broker Recommendation
- eToro Top stock trading platform with 0% commission – Read our Review
- Admiral Markets More than 4500 stocks & over 200 ETFs available to invest in – Read our Review
- BlackBull 26,000+ Shares, Options, ETFs, Bonds, and other underlying assets – Read our Review
- IG Top-tier regulation – Read our Review
- XTB UK regulated by the FCA – Read our Review
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY
FOXO noted that DataRobot is a leader in Value-Driven AI. Furthermore, FOXO has successfully harnessed the powers of predictive AI and high-throughput automation to estimate factors associated with human longevity using epigenetic biomarkers.
Epigenetic biomarkers provide valuable insights into the relationships between health, ageing, and human longevity. These biomarkers are developed by leveraging DNA methylation microarray technology, which covers over 860,000 sites on the human genome.
By leveraging DataRobot's powerful AI platform, FOXO can efficiently analyze vast amounts of complex data, significantly expediting the identification of key biomarkers.
FOXO believes integrating AI and machine learning will enable FOXO to remain at the forefront of epigenetic research, ensuring unparalleled speed and computational capacity for its clients.
FOXO Technologies CEO Tyler Danielson stated: “We believe that with the ability to analyze data at scale, FOXO can uncover critical patterns and associations that hold the potential to reshape healthcare and wellness strategies. Our mission is to enhance human health and longevity through innovative technologies. Collaborating with DataRobot has given us the tools to accelerate our efforts, providing crucial insights into the aging process and ultimately enabling us to improve the quality of life for people worldwide.”
Another significant news release from FOXO was its earnings results on August 10, 2023. The company reported a smaller loss per share of 49 cents compared to $3.84 in the past year.
Today’s rally in FOXO Technologies could be attributed to renewed investor interest in the company.
Foxo Technologies stock price.
The Foxo Technologies stock price rallied 18.86% to trade at $0.1544, from Wednesday’s closing price of $0.1299.
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY.